Sirolimus coated balloon
Sponsors
InnoRa GmbH, Fatebenefratelli and Ophthalmic Hospital, Singapore General Hospital, Fondazione Ricerca e Innovazione Cardiovascolare ETS
Conditions
Angioplasty, Balloon, CoronaryArteriosclerosis, CoronaryArteriovenous Graft OcclusionCoronary Angioplasty, Transluminal BalloonCoronary Artery DiseaseCoronary Artery StenosisCoronary RestenosisDES In-stent Stenosis
Phase 2
Unknown Phase
Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon
CompletedNCT02996318
Start: 2015-12-01End: 2017-12-01Updated: 2021-08-27
The All-comers Sirolimus-coated Balloon European Registry
CompletedNCT03085823
Start: 2016-09-30End: 2022-01-31Updated: 2024-07-31
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon
CompletedNCT03242096
Start: 2017-07-21End: 2021-01-31Updated: 2021-08-27
Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty
NCT04409912
Start: 2021-01-11End: 2024-10-31Target: 170Updated: 2021-08-06
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
Active, not recruitingNCT04893291
Start: 2021-11-16End: 2030-08-30Target: 1820Updated: 2026-02-19